The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89Bio Inc | Common | 282559103 | 2,442,000 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | |||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 4,841,116 | 5,095,912 | SH | SOLE | 5,095,912 | 0 | 0 | |||
Akero Therapeutics Inc | Common | 00973Y108 | 11,262,087 | 392,544 | SH | SOLE | 392,544 | 0 | 0 | |||
ALX Oncology Holdings Inc. | Common | 00166B105 | 4,385,949 | 2,409,862 | SH | SOLE | 2,409,862 | 0 | 0 | |||
Aquestive Therapeutics Inc | Common | 03843E104 | 8,947,815 | 1,796,750 | SH | SOLE | 1,796,750 | 0 | 0 | |||
Arcturus Therapeutics Holdings | Common | 03969T109 | 5,094,781 | 219,508 | SH | SOLE | 219,508 | 0 | 0 | |||
Avidity Biosciences Inc | Common | 05370A108 | 31,644,622 | 688,975 | SH | SOLE | 688,975 | 0 | 0 | |||
Cartesian Therapeutics Inc | Common | 816212302 | 10,146,299 | 629,423 | SH | SOLE | 629,423 | 0 | 0 | |||
Compass Therapeutics, Inc. | Common | 20454B104 | 10,381,085 | 5,641,894 | SH | SOLE | 5,641,894 | 0 | 0 | |||
Crinetics Pharmaceuticals Inc. | Common | 22663K107 | 26,870,680 | 525,845 | SH | SOLE | 525,845 | 0 | 0 | |||
Cullinan Therapeutics, Inc. | Common | 230031106 | 128,032,006 | 7,648,268 | SH | SOLE | 7,648,268 | 0 | 0 | |||
Disc Medicine Inc | Common | 254604101 | 15,319,936 | 311,761 | SH | SOLE | 311,761 | 0 | 0 | |||
Edgewise Therapeutics Inc | Common | 28036F105 | 24,479,161 | 917,166 | SH | SOLE | 917,166 | 0 | 0 | |||
Guardant Health Inc | Common | 40131M109 | 11,450,960 | 499,170 | SH | SOLE | 499,170 | 0 | 0 | |||
Insmed Incorporated | Common | 457669307 | 44,923,543 | 615,391 | SH | SOLE | 615,391 | 0 | 0 | |||
Intellia Therapeutics, Inc. | Common | 45826J105 | 5,498,296 | 267,557 | SH | SOLE | 267,557 | 0 | 0 | |||
Iovance Biotherapeutics Inc | Common | 462260100 | 22,599,044 | 2,406,714 | SH | SOLE | 2,406,714 | 0 | 0 | |||
Janux Therapeutics Inc | Common | 47103J105 | 7,773,300 | 171,105 | SH | SOLE | 171,105 | 0 | 0 | |||
Kalvista Pharmaceuticals Inc | Common | 483497103 | 10,386,276 | 896,915 | SH | SOLE | 896,915 | 0 | 0 | |||
iTeos Therapeutics, Inc. | Common | 46565G104 | 17,826,078 | 1,745,943 | SH | SOLE | 1,745,943 | 0 | 0 | |||
Lantheus Holdings Inc | Common | 516544103 | 16,482,475 | 150,182 | SH | SOLE | 150,182 | 0 | 0 | |||
Madrigal Pharmaceuticals Inc | Common | 558868105 | 15,363,667 | 72,395 | SH | SOLE | 72,395 | 0 | 0 | |||
Mirum Pharmaceuticals Inc | Common | 604749101 | 19,216,197 | 492,723 | SH | SOLE | 492,723 | 0 | 0 | |||
Moonlake Immunotherapeutics | Class A Ord | 61559X104 | 17,599,756 | 349,063 | SH | SOLE | 349,063 | 0 | 0 | |||
Natera Inc | Common | 632307104 | 22,482,718 | 177,099 | SH | SOLE | 177,099 | 0 | 0 | |||
Olema Pharmaceuticals, Inc. | Common | 68062P106 | 32,006,316 | 2,680,596 | SH | SOLE | 2,680,596 | 0 | 0 | |||
PTC Therapeutics Inc | Common | 69366J200 | 3,328,427 | 89,715 | SH | SOLE | 89,715 | 0 | 0 | |||
REGENXBIO Inc. | Common | 75901B107 | 524,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
Relay Therapeutics Inc. | Common | 75943R102 | 14,393,930 | 2,033,041 | SH | SOLE | 2,033,041 | 0 | 0 | |||
Repare Therapeutics, Inc. | Common | 760273102 | 5,641,081 | 1,639,849 | SH | SOLE | 1,639,849 | 0 | 0 | |||
Revolution Medicines, Inc. | Common | 76155X100 | 13,214,582 | 291,391 | SH | SOLE | 291,391 | 0 | 0 | |||
Rocket Pharmaceuticals, Inc. | Common | 77313F106 | 19,695,909 | 1,066,373 | SH | SOLE | 1,066,373 | 0 | 0 | |||
Solid Biosciences Inc | Common | 83422E204 | 80,280 | 11,518 | SH | SOLE | 11,518 | 0 | 0 | |||
Stoke Therapeutics Inc | Common | 86150R107 | 5,892,465 | 479,452 | SH | SOLE | 479,452 | 0 | 0 | |||
Sutro Biopharma, Inc. | Common | 869367102 | 9,798,941 | 2,832,064 | SH | SOLE | 2,832,064 | 0 | 0 | |||
Trevi Therapeutics Inc | Common | 89532M101 | 5,138,647 | 1,538,517 | SH | SOLE | 1,538,517 | 0 | 0 | |||
Twist Bioscience Corp | Common | 90184D100 | 13,324,937 | 294,930 | SH | SOLE | 294,930 | 0 | 0 | |||
Ultragenyx Pharmaceutical Inc | Common | 90400D108 | 18,316,668 | 329,733 | SH | SOLE | 329,733 | 0 | 0 | |||
VIKING THERAPEUTICS INC | Common | 92686J106 | 7,659,370 | 120,982 | SH | SOLE | 120,982 | 0 | 0 | |||
Xenon Pharmaceuticals Inc | Common | 98420N105 | 6,527,546 | 165,800 | SH | SOLE | 165,800 | 0 | 0 | |||
Wave Life Sciences PTE LTD | Common | Y95308105 | 5,120,662 | 624,471 | SH | SOLE | 624,471 | 0 | 0 | |||
Werewolf Therapeutics, Inc. | Common | 95075A107 | 5,062,583 | 2,388,011 | SH | SOLE | 2,388,011 | 0 | 0 | |||
Zentalis Pharmaceuticals, Inc. | Common | 98943L107 | 5,394,148 | 1,465,801 | SH | SOLE | 1,465,801 | 0 | 0 |